Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.

Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic lateral sclerosis (ALS), offering new hope for treating the devastating ...

Researchers have found a new disease-causing mutation in people with amyotrophic lateral sclerosis in a small region of Spain. Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration of motor neurons, leading to muscle weakness and eventually death. While ...

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of developing ALS, a new study finds. Photo by Adobe Stock/HealthDay News People ...

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes progressive muscle weakness. A research team at Tohoku University and Keio University has uncovered a unifying ...

Add Yahoo as a preferred source to see more of our stories on Google. Back in 2008, neurovirologist Renée Douville observed something weird in the brains of people who’d died of the movement disorder ...

The CRISPR gene editing tool has been revolionary for the research lab, and it has also been used to transform the lives of a handful of patients of a few genetic diseases. Now scientists have used ...

Evidence is emerging that amyotrophic lateral sclerosis (ALS) may have an autoimmune component — a finding that, if confirmed, could shape the development of new therapies and prognostic tools.